anmelden
NYSE International 100
10.525,84
PKT
-195,57
PKT
-1,82
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.02.23 | Novartis Sell | Deutsche Bank AG | |
| 02.02.23 | BBVA Neutral | Credit Suisse Group | |
| 02.02.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 02.02.23 | BBVA Buy | Deutsche Bank AG | |
| 02.02.23 | BBVA Neutral | Goldman Sachs Group Inc. | |
| 02.02.23 | Santander Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | Deutsche Bank Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | ING Group Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 02.02.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 02.02.23 | Deutsche Bank Outperform | RBC Capital Markets | |
| 02.02.23 | Santander Sector Perform | RBC Capital Markets | |
| 02.02.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 02.02.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.02.23 | Deutsche Bank Buy | Warburg Research | |
| 02.02.23 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 02.02.23 | BBVA Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.02.23 | UBS Buy | Jefferies & Company Inc. | |
| 02.02.23 | BBVA Outperform | RBC Capital Markets | |
| 01.02.23 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | BBVA Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | Deutsche Telekom Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.23 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 01.02.23 | Deutsche Telekom Outperform | Bernstein Research | |
| 01.02.23 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.02.23 | BBVA Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | Rio Tinto Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | ING Group Buy | Jefferies & Company Inc. | |
| 01.02.23 | Novartis Buy | Jefferies & Company Inc. | |
| 01.02.23 | GSK Hold | Jefferies & Company Inc. | |
| 01.02.23 | BBVA Buy | Jefferies & Company Inc. | |
| 01.02.23 | Vodafone Group Hold | Jefferies & Company Inc. | |
| 01.02.23 | BBVA Outperform | RBC Capital Markets | |
| 01.02.23 | Vodafone Group Market-Perform | Bernstein Research | |
| 01.02.23 | BBVA Buy | UBS AG | |
| 01.02.23 | GSK Sell | UBS AG | |
| 01.02.23 | Novartis Neutral | UBS AG | |
| 01.02.23 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 01.02.23 | UBS Neutral | Credit Suisse Group |